ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
0.432
-0.006
( -1.37% )
Updated: 23:58:01
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.432
Bid
0.432
Offer
0.453
Volume
12,553
0.432 Day's Range 0.445
0.243 52 Week Range 0.499
Previous Close
0.438
Open
0.433
Last Trade
2500
@
0.432
Last Trade Time
23:47:03
Average Volume (3m)
114,359
Financial Volume
-
VWAP
-

SVM Latest News

AT&T Wins $21 Million Contract From ServiceMaster

AT&T Wins $21 Million Contract From ServiceMaster CHICAGO, April 12 /PRNewswire/ -- AT&T announced today that it has won a $21 million integrated networking contract from The ServiceMaster Co...

Net Asset Value & Quarterly Disclosures

The unaudited net asset value per share of SVM OFEX Fund plc at the close of business on 31 December 2003 was as follows:- SVM OFEX Fund 45.34p In accordance with the continuing obligations...

Interim Results

SVM OFEX FUND PLC Results for the six months to 30 September 2003 KEY POINTS * Net Asset Value decreased by 10.3% over the period under review. Net asset value per ordinary share is 49.9p. * Good...

CP 164 DISCLOSURE

The Board of SVM OFEX Fund plc (the "Company") notes the recent publication by the FSA of the Investment Entities (Listing Rules and Conduct of Business) Instrument 2003. In accordance with the...

Net Asset Value(s)

The unaudited net asset value per share of the following Investment Trust at the close of business on 31 August 2003 was as follows:- SVM OFEX Fund 54.39p END

Net Asset Value(s)

The unaudited net asset value per share of the following Investment Trust at the close of business on 31 May 2003 was as follows:- SVM OFEX Fund 54.42p END

Net Asset Value(s)

The unaudited net asset value per share of the following Investment Trust at the close of business on 30 April 2003 was as follows:- SVM OFEX Fund 54.68p END

Final Results

News Release 2 May 2003 SVM OFEX FUND PLC - Results for the year to 31 March 2003 - KEY POINTS * Net asset value declined 34.4% to 55.6p per share, compared to a 34.8% fall in the AIM Index and a...

Net Asset Value(s)

The unaudited net asset value per share of the following Investment Trust at the close of business on 31 March 2003 was as follows:- SVM OFEX Fund plc 56.70p END

Net Asset Value(s)

The unaudited net asset value per share of the following Investment Trust at the close of business on 28 February 2003 was as follows:- SVM OFEX Fund plc 59.15p END

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.01-2.262443438910.4420.4480.4221731870.4246802DE
4-0.063-12.72727272730.4950.4980.4151020140.45526993DE
120.0040.9345794392520.4280.4990.41143590.45287835DE
260.0297.196029776670.4030.4990.3411254410.43001465DE
520.149000152.65023061850.28299990.4990.2431091630.37596886DE
1560.1764.88549618320.2620.4990.2231034750.35134246DE
2600.1764.88549618320.2620.4990.2231034750.35134246DE

SVM - Frequently Asked Questions (FAQ)

What is the current Sovereign Metals share price?
The current share price of Sovereign Metals is 0.432 €
What is the 1 year trading range for Sovereign Metals share price?
Sovereign Metals has traded in the range of 0.243 € to 0.499 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
L7C2Windfall Geotek Inc
0.015 €
(76.47%)
5.47k
W0ICopper Lake Resources Ltd
0.0095 €
(72.73%)
5k
45AAlchemy Resource Ltd
0.007 €
(55.56%)
40k
E3O1Nexoptic Technology Corp
0.0225 €
(50.00%)
2.11k
38ERekor Systems Inc
1.80 €
(44.93%)
110.55k
0PV2Moovly Media Inc
0.002 €
(-55.56%)
388
36GGBM Resources Limited
0.003 €
(-53.85%)
250.36k
R8LVolt Resources Limited
0.0016 €
(-50.00%)
101.43k
EJ7Energy Resources of Australia
0.001 €
(-50.00%)
197k
R1EAEV Resources Ltd
0.001 €
(-44.44%)
10k
PF8European Lithium Limited
0.0248 €
(5.08%)
5.63M
D7GNel ASA
0.2305 €
(-4.95%)
5.18M
B5K3ThreeD Capital Inc
0.149 €
(36.70%)
1.98M
34Q0Quantum eMotion Inc
0.855 €
(9.62%)
1.56M
RD31Royal Helium Ltd
0.02 €
(8.70%)
1.37M

Discussion

View Full Feed
Eagle1 Eagle1 3 minutes ago
Good Morning All, like this one too RVPH 1.8797 0.0797 (4.43%) 12-30-24
RVPH
GTF GTF 3 minutes ago
This mornings incredible post:
https://x.com/ABIntlGroup/status/1873748749572518301
ABQQ
Magnum7419 Magnum7419 3 minutes ago
wow talk about painting the tape............1 share,sold

nasd
10:05:52 0.0009 1 Sell 0.0009 0.001
AHRO
Wayne R Wayne R 4 minutes ago
Where there is life there is hope
bucks2pennies bucks2pennies 4 minutes ago
No report of O/S increase for some time now. 16.8B+ remains the same as of 12/23/24 per OTC
GTCH
threewheeler threewheeler 4 minutes ago
BOPO tax loss selling some body, and nothing we can do about buying these, talk about sux
BOPO
saj saj 4 minutes ago
Buru nice move today over .7
glenn1919 glenn1919 4 minutes ago
erna.......................https://stockcharts.com/h-sc/ui?s=erna&p=W&b=5&g=0&id=p86431144783
ERNA
jour_trader jour_trader 4 minutes ago
Also, the price will be for 30, 60 or 90 bottles so don't we need to take capsule production max of 57K per 8 hour shift and divide by at least 30? We'd then take this and apply it to about 50% of price we see on GoodRx for a reasonable estimate for Elite revenue after pharmacy, distributor & other
ELTP
prototype_101 prototype_101 4 minutes ago
Hero EXACTLY 💯 in addition to Leonberger buying up 100,000 options outright and disposing ZERO, a couple more things he could consider,

1) the latest round of Annual Incentive Comps were issued at $5 strike, and this was at a time the PPS was in 3's

2) the new C
LWLG
AJH92 AJH92 4 minutes ago
Update - December 30: "United States Citizenship and Immigration Services (USCIS) has released processing data for EB-5 visa petitions through Q4 FY2024. The data includes the filings, approvals, denials, and pending cases of Form I-526 legacy, I-526, and I-526E petition for regional center investor
PSRU
tw0122 tw0122 5 minutes ago
.90s +30%%
JDZG
DaJester DaJester 5 minutes ago
One other thing that I think you are misunderstanding: I think Treasury will end up with 80-99.9% of the final share count, i.e. after considering a junior-to-common conversion and capital raise.

I think this is the fundamental difference in theories. It's going to be exceedingly diff
FNMA
stockprofitter stockprofitter 5 minutes ago
He doesn’t work for the government
FNMA
Wayne R Wayne R 5 minutes ago
You sound like Dylan Hunt

https://g.co/kgs/8k8Q7aj
rosemountbomber rosemountbomber 5 minutes ago
They have been waiting for the new formulation to weave its way through the patent and FDA approval processes.

Do we know if they have actually started the approval process with the FDA? Isn't that material information that they would need to release?

Also, I like the
AMRN
tw0122 tw0122 5 minutes ago
.93
JDZG
dexprs dexprs 5 minutes ago
We may have seen the short term bottom this morning. I am changing my tactics accordingly and will be adding larger positions.
FFFacts FFFacts 5 minutes ago
Why do we only see positive statement gains but never losses from the dishonorably discharged?
FNMA
DewDiligence DewDiligence 5 minutes ago
It’s just under 10% of my overall investment portfolio, but it’s about 30% of the drug/biotech portion of my portfolio.
Trooperstocks Trooperstocks 5 minutes ago
$RELT - The acquisition began as early as March of 2023, but its more recent strategic transformation underscores ONAR's visionary drive to position the agency at the forefront of the healthcare marketing industry. As ONAR expands its expertise to new and emerging markets, Of Kos aligns with its rob
RELT
LowFloatLopes LowFloatLopes 5 minutes ago
Bye bye wall 
HOLO
Trooperstocks Trooperstocks 6 minutes ago
$RELT - The acquisition began as early as March of 2023, but its more recent strategic transformation underscores ONAR's visionary drive to position the agency at the forefront of the healthcare marketing industry. As ONAR expands its expertise to new and emerging markets, Of Kos aligns with its rob
RELT
Omar8 Omar8 6 minutes ago
AlwaysRed,





Dropping to fill those last contracts ?


https://www.cmegroup.com/markets/metals/precious/silver.volume.html
SLV
barttt barttt 6 minutes ago
What is our market cap now?  Seems pretty low for owning a 20mil revenue/year furniture company 
ASKH